Reaction
Forced Expiratory Volume Abnormal reporting signals
As of the last recalculation, Forced Expiratory Volume Abnormal appears in 144 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is FLUTICASONE FUROATE (PRR 142.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Fluticasone Furoate | 11 | 142.0 | 142.2 |
| Ciclesonide | 12 | 138.8 | 139.0 |
| Guanfacine | 6 | 115.0 | 115.0 |
| Lumacaftor And Ivacaftor | 5 | 87.3 | 87.4 |
| Mepolizumab | 24 | 83.6 | 83.6 |
| Dornase Alfa | 9 | 70.7 | 70.7 |
| Benralizumab | 6 | 45.2 | 45.2 |